Mandip Mehra congratulated Kazakhstanis on the first unique operation on implantation of a mechanical heart
In the world of domestic heart surgery, a revolutionary breakthrough occurred – for the first time in the world in Astana, two months ago, a unique operation was performed to implant a mechanical heart.
Today, a press conference was held at the information center of the CCS with the participation of the Minister of Health of the Republic of Kazakhstan Yelzhan Birtanov, Chairman of the Board of the National Scientific Cardiac Surgery Center, Doctor of Medical Sciences, 27th President of the World Society of Cardiac Thoracic Surgeons (WSCTS), Chief Cardiac Surgeon of the MHRC Yuri Pya with an international team of surgeons.
We are very pleased to welcome you. A bit cold outside. But we will warm you in Astana thanks to our active discussions. Since 1991, when Kazakhstan declared its independence, the country has shown steady steady growth in various fields, including manufacturing, agriculture, the financial sector, and the social sector. The main goal announced by President Nazarbayev is to improve the quality of life of the population of Kazakhstan and enter the 30 most competitive countries. One of the ways to achieve our goal is to invest in the health sector, said the Minister of Health of Kazakhstan Yelzhan Birtanov at a press conference in the CCS.
The Minister noted that in 2005 the Head of State N Nazarbayev announced that a high-class medical center would be created in our capital Astana in order for Kazakhstanis to receive the most modern treatment.
In 2009, the National Center for Cardiac Surgeons was built and today we are pleased that in a short period of time our National Center has become one of the best cardiac surgery centers in the world. And together with the scientific and political partners of the world, this center shows the best results for the benefit of the people of Kazakhstan so that they can receive these services within the OSMI package, said Minister E. Birtanov.
During the press conference, Yuri Py and international surgeons talked about a new revolutionary heart support system for patients with heart failure, stressing that today this system of the auxiliary device of the left ventricle of the heart is the safest for patients, allowing them to move freely, not burdened with external equipment (cables), which significantly reduces the number of complications and significantly improves the quality of life.
The event was also attended by the first and currently the only patient I.Tursunov, who underwent a unique operation to implant a mechanical heart in Astana last December. Speakers noted that this case was the first in cardiac surgery practice and became unique and unique in the world.
Currently, the operated patient almost returned to a normal lifestyle, has the opportunity not only to do everyday activities, but even to swim, which was not possible using other models of similar devices.
According to Yuri Pya, the new system – the fully implantable circulatory device FIVAD has great prospects in changing the paradigm and approaches in the treatment of end-stage heart failure. We are pleased to present this breakthrough technological achievement, which will allow patients to lead a full and high-quality life after surgery, the doctor said.
Mandip Mehra, MD, a member of the European Society of Cardiology, the chief editor of the Journal of Heart and Lung Transplantation, also spoke at the press conference via Skype.
First of all, I want to congratulate Mr. Minister E. Birtanov, Dr. Pi, Professor Netuk, Dr. Michael. Very nice to see you. I apologize for not being able to come. But, I could not refuse the opportunity to call and congratulate you on the wonderful achievements of Kazakhstan. Indeed, this is a unique success and achievement, a new milestone. I want to tell you about mechanical support for patients with heart failure as it has developed in recent years, he said.
Mandip Mehra noted that first of all, he is a representative of the journal of heart and lung transplants.
We are very pleased to participate in this conference. Our magazine had a debut as an innovation magazine. I want to tell you about the mechanical support of the heart and how it has developed in the past decade. It all started with an ambitious goal in 1964 in the United States. Because the community was at a dead end. We in the 60s thought that we could fly to the moon, and also we thought that we would have a heart artificial pump in order to keep people alive. It just did not happen. We simply could not achieve this. There were innovations over time, later. Only later did we start exploring device design, for example, left ventricular support devices. Dr. Mali and Dr. Netuka and their team were world leaders in translating the latest technologies in the world. For a long time we were disturbed by the fact that we could sustain life with these devices. The devices were improved, but they were not fully placed inside, that is, it was impossible to place them completely in the body. And external support was needed in order to power this device. It was a big problem for us, and we were very pleased when we saw these latest technologies and innovations. When we had the opportunity about this data in the journal of heart and lung transplantations, and we really saw that these scientists were able to advance in this area through collaboration. This is the first step to creating a fully implanted device for the left pancreas. And it happened. I think we should not treat this as a given. I want to congratulate all of you, Dr. Yuri Py and Dr. Dali! Thank you for these achievements.
Mandip Mehra noted that in the first place, when people strive for innovation, it is simply impossible to stop them.
We see that Astana has achieved great success and you are moving this area forward. Now all over the world we see people who are innovators and who are inventing something for the first time, and this requires great courage to achieve a dog. I am not surprised that after the commercial implant, about which you spoke, a new milestone was reached in Astana. I congratulate you once again, he concluded.
Recall, LeviticusCardioLtd., The inventor of wireless power technology for FIVAD, plans to expand its clinical use, reduce risks and improve the quality of heart failure treatment at the last stage. Moreover, this innovation can expand the scope of therapy and provide a technological alternative that is almost equivalent to heart transplantation, which in turn is limited by a shortage of donors.
Founded in 2008, LeviticusCardio (Leviticus-cardio.com) manufactures medical devices that improve clinical outcomes in patients with an implanted left ventricular support device (LVAD) for the treatment of cardiac dysfunction. The company received funding from TheTrendlinesGroup, a leading Israeli investment group dealing with early-stage projects, a consortium of renowned cardiovascular surgery doctors, private investors and the Israel Innovation Authority (formerly the Administrative Division of the Scientific Department of the Ministry of Economics)
The National Scientific Cardiac Surgery Center is the leading medical organization in Central Asia for its innovative and successful work in the field of heart surgery and cardiology. Its main objectives are to improve the health of patients with cardiovascular diseases and the subsequent increase in the life expectancy of the citizens of Kazakhstan. The center aims to improve the quality and efficiency of medical services, the introduction of innovative technologies and the development of research activities. For 7 years since its establishment, the Center was the first to introduce heart and lung transplants in the Central Asian region and the first to introduce left ventricular assisted devices in the Commonwealth of Independent States (former Soviet republics).
Source: Central Communications Service of the Ministry of Information and Communications of the Republic of Kazakhstan